Skip to main content
SpringerLink
Log in

Acetazolamide/fampridine

Lack of efficacy and acetazolamide related toxicities: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Algahtani H, et al. A novel mutation in CACNA1A gene in a Saudi female with episodic ataxia type 2 with no response to acetazolamide or 4-aminopyridine. Intractable and Rare Diseases Research 8: 67-71, No. 1, 28 Feb 2019. Available from: URL: http://doi.org/10.5582/irdr.2018.01133 - Saudi Arabia

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Acetazolamide/fampridine. Reactions Weekly 1750, 15 (2019). https://doi.org/10.1007/s40278-019-60879-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-60879-6

Search

Navigation